Zietchick Research Institute Showcases Futuristic Brain Test at 100 Demo Day
Industry: Healthcare
Zietchick Research Institute (ZRI) Director Tammy Movsas recently introduced to the public a futuristic brain test as part of 100 Demo Day 2019, an entrepreneur competition that took place on August 27 in Grand Rapids, MI. 100 Demo Day—the state of Michigan’s largest entrepreneur competition—is a community-wide investment in the businesses and organizations of tomorrow.
Plymouth, MI (PRUnderground) September 19th, 2019
Doors opened to the public at 20 Monroe Live, Grand Rapids, MI, at 4 p.m., and hundreds of excited attendees rushed in to meet the 100 entrepreneur finalists, see their displays, and hear about their creative ideas for new products. The 100 entrepreneurs were divided into six categories: Food, Product, Service, Retail, Social Impact, and Technology. The categories of Products and Technology had the most participants.
This year, 772 ideas were submitted via video from all over the United States to Start Garden (located in Grand Rapids), and Dr. Tammy Movsas was selected as one of the top 100 finalists on June 19, 2019.
Start Garden created 100 Demo Day as a no-strings-attached way in which to fund people to take shots at new endeavors each year. After being selected as a finalist, each entrepreneur received two months of time and a $1000 award from Start Garden to create his or her display for 100 Demo Day.
The display of Zietchick Research Institute featured a Brain-PRINT (Premature Infant Neurodevelopment Test). According to the institute, no practical or effective way of monitoring infants’ brain development currently exists. Infants born very prematurely, such as those who are born at less than 2.5 lbs, are at a high risk of developing brain development problems. These problems can affect their vision, motor skills, cognitive skills, learning abilities, or behavior.
However, Brain-PRINT is a futuristic way of monitoring the brain development of premature infants by using waste products from dirty diapers. Zietchick Research Institute anticipates that Brain-PRINT will help with identifying infants who would benefit from early intervention, and it will also inspire new therapies for optimizing outcomes for premature infants.
Disclaimer: The news site hosting this press release is not associated with Zietchick Research Institute. It is merely publishing a press release announcement submitted by the company, without any stated or implied endorsement of the product or service.
